<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35038898</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection <i>In Vitro</i>, despite Eliciting a Prolonged Antiviral Response.</ArticleTitle><Pagination><StartPage>e0343621</StartPage><MedlinePgn>e0343621</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e03436-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mbio.03436-21</ELocationID><Abstract><AbstractText>The dynamics of SARS-CoV-2 infection in COVID-19 patients are highly variable, with a subset of patients demonstrating prolonged virus shedding, which poses a significant challenge for disease management and transmission control. In this study, the long-term dynamics of SARS-CoV-2 infection were investigated using a human well-differentiated nasal epithelial cell (NEC) model of infection. NECs were observed to release SARS-CoV-2 virus onto the apical surface for up to 28 days postinfection (dpi), further corroborated by viral antigen staining. Single-cell transcriptome sequencing (sc-seq) was utilized to explore the host response from infected NECs after short-term (3-dpi) and long-term (28-dpi) infection. We identified a unique population of cells harboring high viral loads present at both 3 and 28 dpi, characterized by expression of cell stress-related genes DDIT3 and ATF3 and enriched for genes involved in tumor necrosis factor alpha (TNF-&#x3b1;) signaling and apoptosis. Remarkably, this sc-seq analysis revealed an antiviral gene signature within all NEC cell types even at 28 dpi. We demonstrate increased replication of basal cells, absence of widespread cell death within the epithelial monolayer, and the ability of SARS-CoV-2 to replicate despite a continuous interferon response as factors likely contributing to SARS-CoV-2 persistence. This study provides a model system for development of therapeutics aimed at improving viral clearance in immunocompromised patients and implies a crucial role for immune cells in mediating viral clearance from infected epithelia. <b>IMPORTANCE</b> Increasing medical attention has been drawn to the persistence of symptoms (long-COVID syndrome) or live virus shedding from subsets of COVID-19 patients weeks to months after the initial onset of symptoms. <i>In vitro</i> approaches to model viral or symptom persistence are needed to fully dissect the complex and likely varied mechanisms underlying these clinical observations. We show that <i>in vitro</i> differentiated human NECs are persistently infected with SARS-CoV-2 for up to 28 dpi. This viral replication occurred despite the presence of an antiviral gene signature across all NEC cell types even at 28 dpi. This indicates that epithelial cell intrinsic antiviral responses are insufficient for the clearance of SARS-CoV-2, implying an essential role for tissue-resident and infiltrating immune cells for eventual viral clearance from infected airway tissue in COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gamage</LastName><ForeName>Akshamal M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tan</LastName><ForeName>Kai Sen</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chan</LastName><ForeName>Wharton O Y</ForeName><Initials>WOY</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lew</LastName><ForeName>Zhe Zhang Ryan</ForeName><Initials>ZZR</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chee Wah</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajagopalan</LastName><ForeName>Deepa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Systems Biology and Data Analytics, Genome Institute of Singaporegrid.418377.e, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Quy Xiao Xuan</ForeName><Initials>QXX</Initials><AffiliationInfo><Affiliation>Laboratory of Systems Biology and Data Analytics, Genome Institute of Singaporegrid.418377.e, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Le Min</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Laboratory of Systems Biology and Data Analytics, Genome Institute of Singaporegrid.418377.e, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>Prasanna Nori</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Laboratory of Systems Biology and Data Analytics, Genome Institute of Singaporegrid.418377.e, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Yew Kwang</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thong</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Raymond Tzer Pin</ForeName><Initials>RTP</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Public Health Laboratory, National Centre for Infectious Diseases, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabhakar</LastName><ForeName>Shyam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Systems Biology and Data Analytics, Genome Institute of Singaporegrid.418377.e, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>De Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin-Fa</ForeName><Initials>LF</Initials><Identifier Source="ORCID">0000-0003-2752-0535</Identifier><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SingHealth Duke-NUS Global Health Institute, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">nasal epithelial cells</Keyword><Keyword MajorTopicYN="N">single-cell sequencing</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35038898</ArticleId><ArticleId IdType="pmc">PMC8764519</ArticleId><ArticleId IdType="doi">10.1128/mbio.03436-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qiu X, Nergiz AI, Maraolo AE, Bogoch II, Low N, Cevik M. 2021. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review. Clin Microbiol Infect 27:511&#x2013;519. doi:10.1016/j.cmi.2021.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.01.011</ArticleId><ArticleId IdType="pmc">PMC7825872</ArticleId><ArticleId IdType="pubmed">33484843</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz EA, Richterman A, Bogoch II, Low N, Cevik M. 2021. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2. Lancet Infect Dis 21:e163&#x2013;e169. doi:10.1016/S1473-3099(20)30837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30837-9</ArticleId><ArticleId IdType="pmc">PMC7834404</ArticleId><ArticleId IdType="pubmed">33301725</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2:e13&#x2013;e22. doi:10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Consortium C-GU, Peacock SJ, Robertson DL, COVID-19 Genomics UK (COG-UK) Consortium . 2021. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19:409&#x2013;424. doi:10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. 2021. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunol 14:305&#x2013;316. doi:10.1038/s41385-020-00359-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00359-2</ArticleId><ArticleId IdType="pmc">PMC7690066</ArticleId><ArticleId IdType="pubmed">33244161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schafer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS. 2020. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182:429&#x2013;446.e414. doi:10.1016/j.cell.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamage AM, Tan KS, Chan WOY, Liu J, Tan CW, Ong YK, Thong M, Andiappan AK, Anderson DE, Wang DY, Wang L-F. 2020. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles. PLoS Pathog 16:e1009130. doi:10.1371/journal.ppat.1009130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009130</ArticleId><ArticleId IdType="pmc">PMC7746279</ArticleId><ArticleId IdType="pubmed">33284849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiege JK, Thiede JM, Nanda HA, Matchett WE, Moore PJ, Montanari NR, Thielen BK, Daniel J, Stanley E, Hunter RC, Menachery VD, Shen SS, Bold TD, Langlois RA. 2021. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. PLoS Pathog 17:e1009292. doi:10.1371/journal.ppat.1009292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009292</ArticleId><ArticleId IdType="pmc">PMC7872261</ArticleId><ArticleId IdType="pubmed">33507952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB. 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol 19:e3001143. doi:10.1371/journal.pbio.3001143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001143</ArticleId><ArticleId IdType="pmc">PMC8007021</ArticleId><ArticleId IdType="pubmed">33730024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure X, Duli&#xe8;re V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M. 2020. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. bioRxiv doi:10.1016/j.xcrm.2020.100059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100059</ArticleId><ArticleId IdType="pmc">PMC7373044</ArticleId><ArticleId IdType="pubmed">32835306</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarkoob H, Allue-Guardia A, Chen YC, Jung O, Garcia-Vilanova A, Song MJ, Park JG, Oladunni F, Miller J, Tung YT, Kosik I, Schultz D, Yewdell J, Torrelles JB, Martinez-Sobrido L, Cherry S, Ferrer M, Lee EM. 2021. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents. bioRxiv doi:10.1101/2021.05.11.443693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.11.443693</ArticleId><ArticleId IdType="pmc">PMC9373898</ArticleId><ArticleId IdType="pubmed">35962146</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinen N, Klohn M, Steinmann E, Pfaender S. 2021. In vitro lung models and their application to study SARS-CoV-2 Pathogenesis and disease. Viruses 13:792. doi:10.3390/v13050792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050792</ArticleId><ArticleId IdType="pmc">PMC8144959</ArticleId><ArticleId IdType="pubmed">33925255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. 2005. Well-differentiated human airway epithelial cell cultures. Methods Mol Med 107:183&#x2013;206. doi:10.1385/1-59259-861-7:183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-861-7:183</ArticleId><ArticleId IdType="pubmed">15492373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz Garcia S, Deprez M, Lebrigand K, Cavard A, Paquet A, Arguel MJ, Magnone V, Truchi M, Caballero I, Leroy S, Marquette CH, Marcet B, Barbry P, Zaragosi LE. 2019. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146:978&#x2013;990. doi:10.1242/dev.177428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.177428</ArticleId><ArticleId IdType="pmc">PMC6826037</ArticleId><ArticleId IdType="pubmed">31558434</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JD, Wypych TP. 2021. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol 14:dev177428. doi:10.1038/s41385-020-00370-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00370-7</ArticleId><ArticleId IdType="pmc">PMC7893625</ArticleId><ArticleId IdType="pubmed">33608655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukowy-Bieryllo Z. 2021. Long-term differentiating primary human airway epithelial cell cultures: how far are we? Cell Commun Signal 19:63. doi:10.1186/s12964-021-00740-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-021-00740-z</ArticleId><ArticleId IdType="pmc">PMC8159066</ArticleId><ArticleId IdType="pubmed">34044844</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasschaert LW, Zilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, Klein AM, Jaffe AB. 2018. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560:377&#x2013;381. doi:10.1038/s41586-018-0394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0394-6</ArticleId><ArticleId IdType="pmc">PMC6108322</ArticleId><ArticleId IdType="pubmed">30069046</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BLM. 2009. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA 106:12771&#x2013;12775. doi:10.1073/pnas.0906850106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906850106</ArticleId><ArticleId IdType="pmc">PMC2714281</ArticleId><ArticleId IdType="pubmed">19625615</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, Yuan F, Chen S, Leung HM, Villoria J, Rogel N, Burgin G, Tsankov AM, Waghray A, Slyper M, Waldman J, Nguyen L, Dionne D, Rozenblatt-Rosen O, Tata PR, Mou H, Shivaraju M, Bihler H, Mense M, Tearney GJ, Rowe SM, Engelhardt JF, Regev A, Rajagopal J. 2018. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560:319&#x2013;324. doi:10.1038/s41586-018-0393-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0393-7</ArticleId><ArticleId IdType="pmc">PMC6295155</ArticleId><ArticleId IdType="pubmed">30069044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragosi LE, Deprez M, Barbry P. 2020. Using single-cell RNA sequencing to unravel cell lineage relationships in the respiratory tract. Biochem Soc Trans 48:327&#x2013;336. doi:10.1042/BST20191010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20191010</ArticleId><ArticleId IdType="pubmed">31922198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira Braga FA, Kar G, Berg M, Carpaij OA, Polanski K, Simon LM, Brouwer S, Gomes T, Hesse L, Jiang J, Fasouli ES, Efremova M, Vento-Tormo R, Talavera-Lopez C, Jonker MR, Affleck K, Palit S, Strzelecka PM, Firth HV, Mahbubani KT, Cvejic A, Meyer KB, Saeb-Parsy K, Luinge M, Brandsma CA, Timens W, Angelidis I, Strunz M, Koppelman GH, van Oosterhout AJ, Schiller HB, Theis FJ, van den Berge M, Nawijn MC, Teichmann SA. 2019. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 25:1153&#x2013;1163. doi:10.1038/s41591-019-0468-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0468-5</ArticleId><ArticleId IdType="pubmed">31209336</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen JJA, van de Vijver D, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, van den Akker JPC, Endeman H, Gommers D, Cornelissen JJ, Hoek RAS, van der Eerden MM, Hesselink DA, Metselaar HJ, Verbon A, de Steenwinkel JEM, Aron GI, van Gorp ECM, van Boheemen S, Voermans JC, Boucher CAB, Molenkamp R, Koopmans MPG, Geurtsvankessel C, van der Eijk AA. 2021. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun 12:267. doi:10.1038/s41467-020-20568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20568-4</ArticleId><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, Ang LW, Mak TM, Kalimuddin S, Chai LYA, Pada S, Tan SY, Sun L, Parthasarathy P, Fong SW, Chan YH, Tan CW, Lee B, Rotzschke O, Ding Y, Tambyah P, Low JGH, Cui L, Barkham T, Lin RTP, Leo YS, Renia L, Wang LF, Lye DC, Singapore Novel Coronavirus Outbreak Research Team . 2020. Viral dynamics and immune correlates of COVID-19 disease severity. Clin Infect Dis doi:10.1093/cid/ciaa1280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1280</ArticleId><ArticleId IdType="pmc">PMC7499509</ArticleId><ArticleId IdType="pubmed">32856707</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, Dutta J, van Bakel H, Aberg J, Garcia-Sastre A, Shah G, Hohl T, Papanicolaou G, Perales MA, Sepkowitz K, Babady NE, Kamboj M. 2020. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med 383:2586&#x2013;2588. doi:10.1056/NEJMc2031670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031670</ArticleId><ArticleId IdType="pmc">PMC7722690</ArticleId><ArticleId IdType="pubmed">33259154</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. 2020. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 383:2291&#x2013;2293. doi:10.1056/NEJMc2031364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan GSE, Ding Y, Cui L, Mak TM, Mok CK, Kurup A, Parthasarathy P, Chia WN, Wang LF, Lin RTP, Leo YS, Vasoo S. 2021. Positive RT-PCR detected in patients recovered from COVID-19. Ann Acad Med Singap 50:191&#x2013;194. doi:10.47102/annals-acadmedsg.2020387.</Citation><ArticleIdList><ArticleId IdType="doi">10.47102/annals-acadmedsg.2020387</ArticleId><ArticleId IdType="pubmed">33733267</ArticleId></ArticleIdList></Reference><Reference><Citation>Owusu D, Pomeroy MA, Lewis NM, Wadhwa A, Yousaf AR, Whitaker B, Dietrich E, Hall AJ, Chu V, Thornburg N, Christensen K, Kiphibane T, Willardson S, Westergaard R, Dasu T, Pray IW, Bhattacharyya S, Dunn A, Tate JE, Kirking HL, Matanock A, Household Transmission Study Team . 2021. Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19. J Infect Dis doi:10.1093/infdis/jiab107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab107</ArticleId><ArticleId IdType="pmc">PMC7989388</ArticleId><ArticleId IdType="pubmed">33649773</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397:220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group . 2020. Persistent symptoms in patients after acute COVID-19. JAMA 324:603&#x2013;605. doi:10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. 2021. Attributes and predictors of long COVID. Nat Med 27:626&#x2013;631. doi:10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. 2021. Post-acute COVID-19 syndrome. Nat Med 27:601&#x2013;615. doi:10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon T, Gaudreault NN, Richt JA. 2021. Seasonal stability of SARS-CoV-2 in biological fluids. bioRxiv doi:10.1101/2021.04.07.438866:2021.2004.2007.438866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.07.438866:2021.2004.2007.438866</ArticleId><ArticleId IdType="pmc">PMC8147080</ArticleId><ArticleId IdType="pubmed">33946190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Cai X, Gu C, Zhang R, Han W, Qian Y, Wang Y, Xu W, Wu Y, Cheng X, Yuan Z, Xie Y, Qu D. 2020. Survival of SARS-COV-2 under liquid medium, dry filter paper and acidic conditions. Cell Discov 6:57. doi:10.1038/s41421-020-00191-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00191-9</ArticleId><ArticleId IdType="pmc">PMC7426817</ArticleId><ArticleId IdType="pubmed">32821426</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747&#x2013;1756. doi:10.1084/jem.189.11.1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.189.11.1747</ArticleId><ArticleId IdType="pmc">PMC2193079</ArticleId><ArticleId IdType="pubmed">10359578</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay F, Browning JL. 2002. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465&#x2013;475. doi:10.1038/nri844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri844</ArticleId><ArticleId IdType="pubmed">12094221</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom JR, Luster AD. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89:207&#x2013;215. doi:10.1038/icb.2010.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2010.158</ArticleId><ArticleId IdType="pmc">PMC3863330</ArticleId><ArticleId IdType="pubmed">21221121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S, Ning K, Kuz CA, Vorhies K, Yan Z, Qiu J. 2020. Long-term modeling of SARS-CoV-2 infection of in vitro cultured polarized human airway epithelium. mBio 11:e02852-20. doi:10.1128/mBio.02852-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02852-20</ArticleId><ArticleId IdType="pmc">PMC7649230</ArticleId><ArticleId IdType="pubmed">33158999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yoon GY, Myoung J, Kim SJ, Ahn DG. 2020. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg Microbes Infect 9:2169&#x2013;2179. doi:10.1080/22221751.2020.1827985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1827985</ArticleId><ArticleId IdType="pmc">PMC7580600</ArticleId><ArticleId IdType="pubmed">32969768</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, Loffler B, Baumgart S, Kamradt T, Bauer M. 2021. Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia 35:920&#x2013;923. doi:10.1038/s41375-021-01175-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-021-01175-8</ArticleId><ArticleId IdType="pmc">PMC7893131</ArticleId><ArticleId IdType="pubmed">33608636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp SA, Collier DA, Datir RP, Ferreira I, Gayed S, Jahun A, Hosmillo M, Rees-Spear C, Mlcochova P, Lumb IU, Roberts DJ, Chandra A, Temperton N, COVID-19 Genomics UK (COG-UK) Consortium, Sharrocks K, Blane E, Modis Y, Leigh KE, Briggs JAG, van Gils MJ, Smith KGC, Bradley JR, Smith C, Doffinger R, Ceron-Gutierrez L, Barcenas-Morales G, Pollock DD, Goldstein RA, Smielewska A, Skittrall JP, Gouliouris T, Goodfellow IG, Gkrania-Klotsas E, Illingworth CJR, McCoy LE, Gupta RK. 2021. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592:277&#x2013;282. doi:10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, Lucet JC, Rioux C, Bouzid D, Lebourgeois S, Descamps D, Yazdanpanah Y, Le Hingrat Q, Lescure FX, Visseaux B. 2021. Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection. J Infect Dis 223:1522&#x2013;1527. doi:10.1093/infdis/jiab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab075</ArticleId><ArticleId IdType="pmc">PMC7928754</ArticleId><ArticleId IdType="pubmed">33556961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, Hagglof T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. 2021. Evolution of antibody immunity to SARS-CoV-2. Nature 591:639&#x2013;644. doi:10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, Kergoat L, Kornobis E, Donati F, Cokelaer T, Hervochon R, Madec Y, Roze E, Salmon D, Bourhy H, Lecuit M, Lledo PM. 2021. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 13:eabf8396. doi:10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn JH, Kim J, Hong SP, Choi SY, Yang MJ, Ju YS, Kim YT, Kim HM, Rahman MDT, Chung MK, Hong SD, Bae H, Lee CS, Koh GY. 2021. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in early stage of COVID-19. J Clin Invest 131:e148517. doi:10.1172/JCI148517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148517</ArticleId><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. 2020. Evasion of type I interferon by SARS-CoV-2. Cell Rep 33:108234. doi:10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno Y, Kimura I, Uriu K, Fukushi M, Irie T, Koyanagi Y, Nakagawa S, Sato K. 2020. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant. Cell Rep 32:108185. doi:10.1016/j.celrep.2020.108185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108185</ArticleId><ArticleId IdType="pmc">PMC7473339</ArticleId><ArticleId IdType="pubmed">32941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee AK, Blanco MR, Bruce EA, Honson DD, Chen LM, Chow A, Bhat P, Ollikainen N, Quinodoz SA, Loney C, Thai J, Miller ZD, Lin AE, Schmidt MM, Stewart DG, Goldfarb D, De Lorenzo G, Rihn SJ, Voorhees RM, Botten JW, Majumdar D, Guttman M. 2020. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183:1325&#x2013;1339.e1321. doi:10.1016/j.cell.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, Kratzat H, Hayn M, Mackens-Kiani T, Cheng J, Straub JH, St&#xfc;rzel CM, Fr&#xf6;hlich T, Berninghausen O, Becker T, Kirchhoff F, Sparrer KMJ, Beckmann R. 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369:1249&#x2013;1255. doi:10.1126/science.abc8665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, Grzelak L, Planas D, Dufloo J, Gellenoncourt S, Bongers A, Zivaljic M, Planchais C, Guivel-Benhassine F, Porrot F, Mouquet H, Chakrabarti L, Buchrieser J, Schwartz O. 2021. SARS-CoV-2 alpha, beta and delta variants display enhanced spike-mediated syncytia formation. bioRxiv doi:10.1101/2021.06.11.448011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.448011</ArticleId><ArticleId IdType="pmc">PMC8646911</ArticleId><ArticleId IdType="pubmed">34601723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Tan KS, Li C, Tran T, Chao SS, Sugrue RJ, Shi L, Chow V, Wang D-Y. 2016. Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol 138:276&#x2013;281. doi:10.1016/j.jaci.2015.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.11.016</ArticleId><ArticleId IdType="pubmed">26806046</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P, Giladi A, Liu Y, Bendjelal Y, Xu G, David E, Blecher-Gonen R, Cohen M, Medaglia C, Li H, Deczkowska A, Zhang S, Schwikowski B, Zhang Z, Amit I. 2020. Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell 181:1475&#x2013;1488.e1412. doi:10.1016/j.cell.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7205692</ArticleId><ArticleId IdType="pubmed">32479746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>